Biotechnology entrepreneur to speak on starting a tech business

(Sept. 16, 2002)--The UTSA College of Sciences will host a seminar featuring Matt Winkler, CEO and founder of Ambion: The RNA Company, at 11 a.m. Wednesday, Sept. 18 in the Biosciences Building Room 3.03.02 on the 1604 Campus. The presentation is open to the public, but may be of particular interest to faculty and graduate students in science, engineering and business.

Winkler is the first speaker in a series on faculty entrepreneurship. Based on his personal experiences, he will discuss the “dos and don’ts” of the technology business start-up process.

Through presenting the work of successful entrepreneurs with academic origins, and providing information on the range of topics concerning academic technology transfer, the series aims to encourage the development of a culture of commercial enterprise among UTSA scientific and engineering faculty.

Founding the company in 1989, Winkler developed Austin-based Ambion into one of the most successful biotechnology start-up firms in Texas. Having earned tenure at UT Austin, Winkler decided to build on his activities by providing research colleagues with molecular-biology reagents, which are used in preparing products.

With current revenue of more than $25 million, Ambion develops and markets its products to organizations around the world. Winkler remains CEO as well as chief scientific officer of the company, and was named the 2002 winner of the Ernst & Young Entrepreneur of the Year award.

For more information, call (210) 458-4450.

----------------------------------------------------------

TODAY'S HEADLINES:

UTSA presents panel discussion on 'year after'
UTSA TechConnect Project hosts second-year celebration
Mayor proclaims Sept. 16-22 'Mentoring Week in San Antonio'
Latino Heritage Week continues through Sept. 21
UTSA science researchers study rare West Texas trees
Counseling services announces new support groups
Biotechnology entrepreneur to speak on starting a tech business

UTSA Today Front Page

----------------------------------------------------------